Víctor Jiménez-Yuste

69PUBLICATIONS
146CO-AUTHORS
HaematologyGene and molecular therapyCardiology (incl. cardiovascular diseases)Econometric and statistical methodsAdolescent health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (69)

|Sep 21, 2026
A Common Language for the Multidisciplinary Team: Point-of-Care Musculoskeletal Ultrasound in Modern Haemophilia Care.

|Nov 27, 2025
Real-World Experience with Eptacog Beta for On-Label and Off-Label Indications: The Spanish Experience.

Jose Manuel Martin de Bustamante, María Isabel Rivas-Pollmar, Natalia Acedo

|Jul 17, 2025
Qualification Criteria of Gene Therapy for Haemophilia-Opinion of the EAHAD Gene Therapy Working Group.

Wolfgang Miesbach, Ana Boban, Pratima Chowdary

|Jun 19, 2025
Pain Reduction Following Eptacog Beta Treatment of Bleeding Episodes in Adolescents and Adults With Haemophilia A or B Complicated by Inhibitors.

Tyler W Buckner, Craig Kessler, Giancarlo Castaman

|May 14, 2025
Concizumab, a Non-Replacement Therapy for Persons with Hemophilia with Inhibitors.

Giancarlo Castaman, Victor Jimenez-Yuste, Johnny Mahlangu

|Dec 16, 2024
Bleed treatment with eptacog beta (rFVIIa) results in a low incidence of rebleeding in adult and adolescent patients with haemophilia A or B with inhibitors.

Amy Dunn, Yesim Dargaud, Yasmina Abajas

Pageof 12